Biomarkers could help identify ICU patients at risk of chronic critical illness

by American Association of Immunologists

edited by Sadie Harley, reviewed by Robert Egan

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

New research, published in The Journal of Immunology, identifies biomarkers of a distinct immune profile that could be used to identify patients at risk for chronic critical illness (CCI) on admission to the intensive care unit (ICU) after traumatic injury. Identifying which patients are at increased risk for CCI could allow doctors to intervene earlier, leading to shorter ICU stays and improved patient outcomes.

"Our findings are highly novel, challenging what scientists have long thought about the immune changes that cause organ dysfunction and mortality in severely injured trauma patients. Rather than the immune system being exhausted, our data show overactivity and dysfunction," said Dr. Scott Brakenridge, professor of surgery at the University of Washington and senior author of the study.

Severe traumatic injury, such as from a car crash or fall, causes changes to the immune system that can lead to immune and organ dysfunction, as well as recurrent infections. Researchers have long thought this was due to a deficiency in an immune signal, or cytokine, called interferon-gamma (IFN𝛾), which regulates immune responses.

While CCI, which describes patients who remain dependent on ICU care for more than 14 days, is related to these immune changes, clinicians did not know what drove the disease.

A different immune pattern emerges

This new research shows that CCI patients exhibited increased numbers of immune cells, including neutrophils, a type of T cell called Th17, and amplified inflammatory cytokines, including IFN𝛾 and IL-17A. These markers indicate a patient's immune system is inducing a misdirected or imbalanced response. This immune profile was distinctly different from that of trauma patients who recovered within 14 days.

"As the immune changes observed in CCI patients are distinct from those in patients who recover before 14 days, these findings reveal immunological features that may be used to quickly identify trauma patients at risk for CCI when they are admitted to the ICU. Developing a test for this profile would allow clinicians to tailor patient care, quickening recovery time and saving lives," explained Caleb Kim, a Ph.D. candidate at the University of Minnesota and first author of the paper.

Traumatic injury triggers a dynamic immune response that can increase inflammation or immune dysregulation. Trauma patients are also susceptible to infections during their stay in the ICU, which can prolong or complicate their recovery. However, only about 20% of trauma patients develop CCI.

Tracking patients over time

To understand what drives CCI, researchers collected blood samples from blunt/penetrating trauma patients admitted to the ICU on days 4, 7, 10, 14 and 28 of their ICU stay, or until they were discharged. Patients were sorted into groups based on the length of their stay, with rapid recovery (RR) patients discharged within seven days, intermediate (IM) patients discharged between days 7 and 14, and CCI patients admitted longer than 14 days.

The researchers compared blood samples from the different groups to determine any differences that may explain why some patients developed CCI.

"IL-17A was the most informative marker that distinguished CCI patients from RR or IM. Some CCI patients had elevated IL-17A even at day 1 in the ICU, suggesting almost immediate immune dysregulation," Brakenridge said.

"Understanding that CCI patients do not simply experience an early failure of immunity but rather a misdirected or imbalanced response is critical to developing early interventions to help patients at risk for CCI," Brakenridge continued.

The researchers plan to build on these findings by further delineating the immune mechanisms driving CCI.

Publication details

Distinct immune trajectories after severe trauma identify a Th17-biased immunophenotype in chronic critical illness, The Journal of Immunology (2026). DOI: 10.1093/jimmun/vkag125

Journal information: Journal of Immunology

Key medical concepts

IL17A protein, humanInterferon gamma [EPC]Neutrophils

Clinical categories

Critical care medicineAllergy and immunology Provided by American Association of Immunologists Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Biomarkers could help identify ICU patients at risk of chronic critical illness (2026, June 25) retrieved 25 June 2026 from https://medicalxpress.com/news/2026-06-biomarkers-icu-patients-chronic-critical.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.